New treatments for chronic hepatitis C: An overview for paediatricians

doi:10.3748/wjg.v20.i43.15965

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 43

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7263)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

484

WORD

239

HTML

3273

Figures (1-1)

172

Tables (1-1)

120

Sum=4288

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1280

Download

1695

Sum=2975

Nov 21, 2014 (publication date) through Apr 24, 2024

Times Cited of This Article

Times Cited (11)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. Nov 21, 2014; 20(43): 15965-15974
Published online Nov 21, 2014. doi: 10.3748/wjg.v20.i43.15965

Open in New Tab Full Size Figure Download Figure

Figure 1 Association of direct-acting antiviral agents in chronic hepatitis C treatment. PEG-IFN: Pegylated interferon; RIBA: Ribavirin; NI: Nucleoside inhibitor; PI: Protease inhibitor; NS5A: NS5A inhibitor; NNI: Non-nucleoside inhibitor; DAA: Direct-acting antiviral agent.

Citation: Serranti D, Indolfi G, Resti M. New treatments for chronic hepatitis C: An overview for paediatricians. World J Gastroenterol 2014; 20(43): 15965-15974
URL: https://www.wjgnet.com/1007-9327/full/v20/i43/15965.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i43.15965